When serum sLAG-3 levels were examined in patients with gastric cancer (GC), its expression correlated with TNM stage, depth of tumour invasion and degree of tumour differentiation in addition to positively correlating with IL-12 and IFN-γ levels [69]. The gene discussed is LAG3; the disease is neoplasm.